4-4274590-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017816.3(LYAR):c.609G>T(p.Lys203Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00136 in 1,613,622 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 2 hom. )
Consequence
LYAR
NM_017816.3 missense
NM_017816.3 missense
Scores
7
9
Clinical Significance
Conservation
PhyloP100: 1.69
Genes affected
LYAR (HGNC:26021): (Ly1 antibody reactive) Enables several functions, including DNA-binding transcription factor binding activity; identical protein binding activity; and transcription regulator inhibitor activity. Involved in several processes, including erythrocyte development; negative regulation of innate immune response; and regulation of transcription, DNA-templated. Located in nucleolus and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.046969414).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYAR | NM_017816.3 | c.609G>T | p.Lys203Asn | missense_variant | 7/10 | ENST00000343470.9 | NP_060286.1 | |
LYAR | NM_001145725.2 | c.609G>T | p.Lys203Asn | missense_variant | 7/10 | NP_001139197.1 | ||
LYAR | XM_011513505.2 | c.609G>T | p.Lys203Asn | missense_variant | 7/10 | XP_011511807.1 | ||
LYAR | XM_011513506.4 | c.609G>T | p.Lys203Asn | missense_variant | 6/9 | XP_011511808.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYAR | ENST00000343470.9 | c.609G>T | p.Lys203Asn | missense_variant | 7/10 | 1 | NM_017816.3 | ENSP00000345917.4 | ||
LYAR | ENST00000452476.5 | c.609G>T | p.Lys203Asn | missense_variant | 7/10 | 1 | ENSP00000397367.1 |
Frequencies
GnomAD3 genomes AF: 0.00103 AC: 157AN: 152164Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
157
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000774 AC: 194AN: 250620Hom.: 1 AF XY: 0.000760 AC XY: 103AN XY: 135464
GnomAD3 exomes
AF:
AC:
194
AN:
250620
Hom.:
AF XY:
AC XY:
103
AN XY:
135464
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00140 AC: 2040AN: 1461340Hom.: 2 Cov.: 32 AF XY: 0.00133 AC XY: 967AN XY: 726978
GnomAD4 exome
AF:
AC:
2040
AN:
1461340
Hom.:
Cov.:
32
AF XY:
AC XY:
967
AN XY:
726978
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00103 AC: 157AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000860 AC XY: 64AN XY: 74454
GnomAD4 genome
AF:
AC:
157
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
64
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
10
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
12
ExAC
AF:
AC:
78
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.609G>T (p.K203N) alteration is located in exon 7 (coding exon 5) of the LYAR gene. This alteration results from a G to T substitution at nucleotide position 609, causing the lysine (K) at amino acid position 203 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Vest4
MutPred
Gain of sheet (P = 0.0221);Gain of sheet (P = 0.0221);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at